Recipharm, a Swedish contract development and manufacturing organization in the pharmaceutical sector, has signed an agreement to purchase 74% of the shares Nitin Lifesciences, an Indian sterile injectables contract manufacturing company.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.